Axsome Therapeutics, Inc. (0HKF.L)
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
$218.62-0.06%
StockGlow Score
Bullish
BearishBullish
1 year ago+112.1%
The outlook
Axsome Therapeutics, Inc. currently reads as bullish based on above its 50- & 200-day averages, 89% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range89% of the way from its 52-week low to high
Market cap
—
52-wk high
$238.00
52-wk low
$55.64
50-day avg
$85.35
200-day avg
$75.30
Trailing P/E
—